Lutikizumab

5 trials 4 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

1 Completed trials

1 Sponsors

25 Countries

Phase III

Phase II

Phase III: 1 Phase II: 4

Oversight events:

2 corrective measures across 1 trial

View oversight register →

Indications tested

Colitis ulcerative 1 Rheumatoid arthritis 1 Crohn's disease 1

Sponsors using this IMP

AbbVie Deutschland GmbH & Co. KG 5

All trials

5 total

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis Recruiting

2025-520721-21-00 Phase II 6 countries AbbVie Deutschland GmbH & Co. KG
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participant… Recruiting

2023-505678-14-00 Phase II 18 countries AbbVie Deutschland GmbH & Co. KG
A Phase 2 Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Active Psoriatic Arthritis Recruiting

2024-519291-11-00 Phase II 4 countries AbbVie Deutschland GmbH & Co. KG
Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting

2024-513009-30-00 Phase II 23 countries AbbVie Deutschland GmbH & Co. KG
Hidradenitis Suppurativa: Evaluation of lutikizumab in Adult and Adolescent Subjects Ended

2024-510730-40-00 Phase III 22 countries AbbVie Deutschland GmbH & Co. KG

Showing 1–5 of 5 trials

← All drugs A–Z